ClassID:

94595

C07D251/18 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Recent Application in this class:
#1
20250382272
2025-12-18

CRYSTALLINE FORM OF INDAZIFLAM, METHODS FOR ITS PREPARATION AND USE THEREOF

#2
20250382262
2025-12-18

PROCESS FOR THE PREPARATION OF BIGUANIDINE SALTS AND TRIAZINES

#3
20250304571
2025-10-02

BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF

#4
20250136561
2025-05-01

COMPOSITIONS OF MATTER FROM UNSATURATED NITRILES

#5
20240383866
2024-11-21

2,4,6-TRISUBSTITUTED 1,3,5-TRIAZINES AS MODULATORS OF CX3CR1

#6
20240335448
2024-10-10

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#7
20240251591
2024-07-25

COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME

#8
20240199558
2024-06-20

2,4,6-TRISUBSTITUTED 1,3,5-TRIAZINES AS MODULATORS OF CX3CR1

#9
20240150303
2024-05-09

DIAMINOTRIAZINE COMPOUNDS

#10
20240101521
2024-03-28

DIAMINOTRIAZINE COMPOUNDS

#11
20230250078
2023-08-10

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#12
20230107499
2023-04-06

HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE

#13
20230044670
2023-02-09

Compounds and compositions for ossification and methods related thereto

#14
20220354856
2022-11-10

Therapeutically active compounds and their methods of use

#15
20220348554
2022-11-03

Therapeutically active compounds and their methods of use

#16
20220135535
2022-05-05

Heteroaryl compounds and their use

#17
20220000878
2022-01-06

METHODS OF TREATMENT OF MALIGNANCIES

#18
20210403647
2021-12-30

Triazine-based polymer

#19
20210186021
2021-06-24

Diaminotriazine compounds

#20
20210179938
2021-06-17

Anti-oxidant compounds and compositions

#21
20210100806
2021-04-08

Compounds and compositions for ossification and methods related thereto

#22
20200383329
2020-12-10

DIAMINOTRIAZINE COMPOUNDS

#23
20200190042
2020-06-18

2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof

#24
20200121687
2020-04-23

Compounds and compositions for ossification and methods related thereto

#25
20200079755
2020-03-12

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#26
20190337922
2019-11-07

Heteroaryl compounds and their use

#27
20190262497
2019-08-29

Therapeutic acrylates as enhanced medical adhesives

#28
20190256493
2019-08-22

Diphenylaminopyrimidine and triazine compound, and pharmaceutical composition and use thereof

#29
20190144399
2019-05-16

2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof

#30
20190117661
2019-04-25

Therapeutically active compounds and their methods of use

#31
20190111060
2019-04-18

Substituted carbonucleoside derivatives useful as anticancer agents

#32
20190092736
2019-03-28

Compositions and methods to produce alkoxylated triazine-arlhydroxy-aldehyde condensates

#33
20190076380
2019-03-14

Biguanide compositions and methods of treating metabolic disorders

#34
20190062308
2019-02-28

1,3,5-triazine derivative and method of using same

#35
20190015413
2019-01-17

Acrylanilide derivative, preparation method, and applications thereof in pharmacy

#36
20180207166
2018-07-26

Compounds and compositions for ossification and methods related thereto

#37
20180022715
2018-01-25

N-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine

#38
20180008561
2018-01-11

Compositions and methods for treating metabolic disorders

#39
20170348318
2017-12-07

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

#40
20170348313
2017-12-07

Substituted carbonucleoside derivatives useful as anticancer agents

#41
20170298045
2017-10-19

Therapeutically active compounds and their methods of use

#42
20170233353
2017-08-17

Process for the preparation of triazine carbamates

#43
20170166591
2017-06-15

Therapeutic agent for treating tumors

#44
20170165209
2017-06-15

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#45
20170157132
2017-06-08

Methods of treatment of malignancies

#46
20170107194
2017-04-20

Therapeutically active compounds and their methods of use

#47
20170073331
2017-03-16

Guanidine compounds and use thereof

#48
20170057953
2017-03-02

Compositions useful for treating disorders related to kit

#49
20170050954
2017-02-23

Diaminotriazine compounds as herbicides

#50
20170050935
2017-02-23

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#51
20170044139
2017-02-16

Therapeutically active compounds and their methods of use

#52
20170044114
2017-02-16

Diaminotriazine compounds and their use as herbicides

#53
20170035771
2017-02-09

Compounds and compositions for ossification and methods related thereto

#54
20170029384
2017-02-02

Diaminotriazine derivatives as herbicides

#55
20170029383
2017-02-02

Diaminotriazine Derivatives as Herbicides

#56
20170022170
2017-01-26

Diaminotriazine derivatives as herbicides

#57
20160318903
2016-11-03

Therapeutically active compositions and their methods of use

#58
20160220572
2016-08-04

Therapeutically active compounds and their methods of use

#59
20160213675
2016-07-28

Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

#60
20160159771
2016-06-09

Therapeutically active compounds and their methods of use

#61
20160158241
2016-06-09

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

#62
20160095828
2016-04-07

Compositions and methods for treating metabolic disorders

#63
20160039761
2016-02-11

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#64
20150376148
2015-12-31

Process for the preparation of triazine carbamates

#65
20150283146
2015-10-08

Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase

#66
20150210652
2015-07-30

Substituted triazines for malaria treatment and chemoprophylaxis

#67
20150196509
2015-07-16

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#68
20150183753
2015-07-02

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#69
20150018328
2015-01-15

Therapeutically active compounds and their methods of use

#70
20150011752
2015-01-08

Triazine compounds as PI3 kinase and MTOR inhibitors

#71
20150011751
2015-01-08

NOVEL TRIAZINE DERIVATIVE

#72
20140341986
2014-11-20

Biguanide compositions and methods of treating metabolic disorders

#73
20140228338
2014-08-14

Topical ocular analgesic agents

#74
20140203212
2014-07-24

Fluorescent whitening agent aqueous solutions

#75
20130190287
2013-07-25

Therapeutically active compounds and their methods of use

#76
20130177604
2013-07-11

Compositions and methods of treating metabolic disorders

#77
20130137635
2013-05-30

TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE

#78
20130137634
2013-05-30

Compounds and compositions for ossification and methods related thereto

#79
20130095140
2013-04-18

Biguanide compositions and methods of treating metabolic disorders

#80
20130005723
2013-01-03

Triazine compounds as PI3 kinase and mTOR inhibitors

#81
20120202806
2012-08-09

Novel Pyrimidine- And Triazine-Hepcidine Antagonists

#82
20120172364
2012-07-05

Rate-controlled particles

#83
20120157484
2012-06-21

Tryptophan hydroxylase inhibitors

#84
20120142920
2012-06-07

Triazine derivatives for use in the treatment of malaria

#85
20120101287
2012-04-26

Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators

#86
20120071482
2012-03-22

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#87
20120009151
2012-01-12

Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof

#88
20110312955
2011-12-22

Triazine compounds as PI3 kinase and mTOR inhibitors

#89
20110275762
2011-11-10

Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes

#90
20110275641
2011-11-10

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#91
20110275640
2011-11-10

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#92
20110178212
2011-07-21

Method for producing a compound with at least one at least monosubstituted amino group

#93
20110105654
2011-05-05

Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group

#94
20110098363
2011-04-28

AMPHIPHILIC MOLECULES WITH A TRIAZINE CORE

#95
20110092490
2011-04-21

PYRIMIDINES, TRIAZINES AND THEIR USE AS PHARMACEUTICAL AGENTS

#96
20110053907
2011-03-03

SUBSTITUTED PYRIMIDINES AND TRIAZINES AND THEIR USE IN CANCER THERAPY

#97
20100331329
2010-12-30

Benzamide derivatives useful as histone deacetylase inhibitors

#98
20100280054
2010-11-04

Multicyclic amino acid derivatives and methods of their use

#99
20100249137
2010-09-30

sEH inhibitors and their use

#100
20100210656
2010-08-19

sEH inhibitors and their use

#101
20100160343
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#102
20100160341
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#103
20100129350
2010-05-27

Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives

#104
20100127616
2010-05-27

COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE

#105
20100120722
2010-05-13

HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS

#106
20100113456
2010-05-06

Therapeutic agent for corneal disease

#107
20100099658
2010-04-22

Di(arylamino)aryl compounds

#108
20100044695
2010-02-25

Compound for organic electroluminescent device and organic electroluminescent device

#109
20090304692
2009-12-10

TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS

#110
20090291079
2009-11-26

Triazine compounds as PI3 kinase and mTOR inhibitors

#111
20090286809
2009-11-19

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#112
20090286794
2009-11-19

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#113
20090192134
2009-07-30

Compounds

#114
20090148531
2009-06-11

RATE-CONTROLLED PARTICLES

#115
20090030001
2009-01-29

THERAPEUTIC AGENT FOR CORNEAL DISEASE

#116
20090029991
2009-01-29

BENZAMIDE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS

#117
20090005250
2009-01-01

Substituted 2,4-diamino-1,3,5-triazines, processes for their use as herbicides and crop growth regulators

#118
20080255353
2008-10-16

METHOD FOR PREPARING MELAMINE SALT OF BIS(PENTAERYTHRITOL PHOSPHATE) PHOSPHORIC ACID

#119
20080182846
2008-07-31

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#120
20080064700
2008-03-13

Aryl triazines as LPAAT-β inhibitors and uses thereof

#121
20080058297
2008-03-06

Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss

#122
20080051404
2008-02-28

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#123
20070293399
2007-12-20

SUBSTITUTED DIAMINO-1,3,5-TRIAZINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND CROP GROWTH REGULATORS

#124
20070238617
2007-10-11

Diamino-1,3,5-triazines N-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators

#125
20070191370
2007-08-16

Multicyclic amino acid derivatives and methods of their use

#126
20070179263
2007-08-02

Functional material comprising fluorine-containing compound

#127
20070099921
2007-05-03

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#128
20070083047
2007-04-12

Preparation of alkoxycarbonylaminotriazines

#129
20070049592
2007-03-01

Bis-aryl urea compounds and methods of use

#130
20060189614
2006-08-24

Substituted diamino-1,3,5-triazine derivatives

#131
20060153783
2006-07-13

Triazine derivatives as UV absorbers

#132
20060063739
2006-03-23

2-substituted heteroaryl compounds

#133
20060058298
2006-03-16

Inhibitors of histone deacetylase

#134
20060004005
2006-01-05

Triazines derivatives as cell adhesion inhibitors

#135
20050288282
2005-12-29

Inhibitors of histone deacetylase

#136
20050261293
2005-11-24

Compounds which inhibit leukocyte adhesion mediated by VLA-4

#137
20050250945
2005-11-10

Triazine compounds as inhibitors of bacterial type III protein secretion systems

#138
20050245499
2005-11-03

Heterocyclic protein kinase inhibitors and uses thereof

#139
20050222412
2005-10-06

Peptide deformylase inhibitors

#140
20050222152
2005-10-06

Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives

#141
20050203093
2005-09-15

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#142
20050171104
2005-08-04

Novel thyroid receptor ligands

#143
20050171103
2005-08-04

Benzamide derivatives useful as histone deacetylase inhibitors

#144
20050054732
2005-03-10

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#145
15713577
2018-11-06

Compositions and methods to produce Alkoxylated triazine-arylhydroxy-aldehyde condensates